S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
NASDAQ:CRNC

Cerence (CRNC) Stock Price, News & Analysis

$10.35
0.00 (0.00%)
(As of 04/19/2024 ET)
Today's Range
$9.98
$10.59
50-Day Range
$10.35
$16.53
52-Week Range
$9.98
$36.79
Volume
544,520 shs
Average Volume
359,651 shs
Market Capitalization
$431.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$20.83

Cerence MarketRank™ Stock Analysis

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
101.3% Upside
$20.83 Price Target
Short Interest
Bearish
17.54% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.68
Upright™ Environmental Score
News Sentiment
0.00mentions of Cerence in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$379,765 Sold Last Quarter
Proj. Earnings Growth
-92.59%
From $0.54 to $0.04 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.52 out of 5 stars

Computer And Technology Sector

322nd out of 581 stocks

Prepackaged Software Industry

115th out of 197 stocks

CRNC stock logo

About Cerence Stock (NASDAQ:CRNC)

Cerence Inc. provides AI powered virtual assistants for the mobility/transportation market in United States, Other Americas, Germany, Europe, Middle East, Africa, Japan, and Other Asia-Pacific. The company offers edge software components, cloud-connected components, virtual assistant coexistence, and professional services. It also provides conversational artificial intelligence-based solutions, including speech recognition, natural language understanding, speech signal enhancement, text-to-speech, and acoustic modeling technology. Cerence Inc. is headquartered in Burlington, Massachusetts.

CRNC Stock Price History

CRNC Stock News Headlines

Analyst Scoreboard: 4 Ratings For Cerence
Start loving Mondays like this
Wouldn’t you love to start looking forward to Mondays? We’re in a New Paradigm Shift in the market that could make it possible! You see, rallies over the weekends have become much more common in the last few years. Imagine hitting a few buttons on your phone or laptop to place a quick trade before the weekend hits… And coming back on Monday to what could be extra income sitting in your account… Weekend after weekend!
3 Tech Stocks to Buy to Triple Your Investment by 2025
Start loving Mondays like this
Wouldn’t you love to start looking forward to Mondays? We’re in a New Paradigm Shift in the market that could make it possible! You see, rallies over the weekends have become much more common in the last few years. Imagine hitting a few buttons on your phone or laptop to place a quick trade before the weekend hits… And coming back on Monday to what could be extra income sitting in your account… Weekend after weekend!
CRNC Apr 2024 15.000 put
CRNC Apr 2024 20.000 call
Cerence: Poised For Rebound With Strong Pipeline
Cerence Appoints Daniel Tempesta To Succeed Tom Beaudoin As CFO
Cerence’s Mixed Financial Signals Prompt Hold Rating
Craig-Hallum gets more bearish on Cerence, downgrades shares
Q1 2024 Cerence Inc Earnings Call
What Wall Street expects from Cerence's earnings
Cerence drops 5%, guides FQ2 revenue below estimates
See More Headlines
Receive CRNC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cerence and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/06/2024
Today
4/20/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
9/30/2024

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
NASDAQ:CRNC
Fax
N/A
Employees
1,700
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$20.83
High Stock Price Target
$25.00
Low Stock Price Target
$15.00
Potential Upside/Downside
+101.3%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
6 Analysts

Profitability

Net Income
$-56,250,000.00
Pretax Margin
6.51%

Debt

Sales & Book Value

Annual Sales
$294.48 million
Book Value
$17.23 per share

Miscellaneous

Free Float
41,179,000
Market Cap
$431.28 million
Optionable
Optionable
Beta
2.46
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Dr. Stefan OrtmannsDr. Stefan Ortmanns (Age 60)
    President, CEO & Director
    Comp: $1.18M
  • Mr. Iqbal Arshad (Age 62)
    Executive VP & CTO
    Comp: $906.7k
  • Mr. Thomas L. Beaudoin (Age 71)
    Executive Officer & Director
    Comp: $868.08k
  • Mr. Daniel D. Tempesta (Age 54)
    Chief Financial Officer
  • Ms. Jennifer Salinas
    Senior VP, General Counsel & Secretary
  • Mr. Sachin Sahney
    Chief Human Resources Officer
  • Mr. Sujal Shah
    Head of Professional Services
  • Mr. Nils Schanz
    Chief Product Officer
  • Mr. Christian Mentz
    Chief Revenue Officer
  • Dennis J. Close
    VP & Treasurer

CRNC Stock Analysis - Frequently Asked Questions

Should I buy or sell Cerence stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cerence in the last twelve months. There are currently 4 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" CRNC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CRNC, but not buy additional shares or sell existing shares.
View CRNC analyst ratings
or view top-rated stocks.

What is Cerence's stock price target for 2024?

6 Wall Street analysts have issued 1 year price targets for Cerence's stock. Their CRNC share price targets range from $15.00 to $25.00. On average, they predict the company's stock price to reach $20.83 in the next twelve months. This suggests a possible upside of 101.3% from the stock's current price.
View analysts price targets for CRNC
or view top-rated stocks among Wall Street analysts.

How have CRNC shares performed in 2024?

Cerence's stock was trading at $19.66 at the beginning of 2024. Since then, CRNC stock has decreased by 47.4% and is now trading at $10.35.
View the best growth stocks for 2024 here
.

Are investors shorting Cerence?

Cerence saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 6,290,000 shares, an increase of 10.7% from the March 15th total of 5,680,000 shares. Based on an average daily volume of 469,300 shares, the short-interest ratio is presently 13.4 days. Currently, 17.5% of the shares of the company are sold short.
View Cerence's Short Interest
.

When is Cerence's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our CRNC earnings forecast
.

How were Cerence's earnings last quarter?

Cerence Inc. (NASDAQ:CRNC) posted its quarterly earnings results on Tuesday, February, 6th. The company reported $0.95 earnings per share for the quarter, beating analysts' consensus estimates of $0.72 by $0.23. The company had revenue of $138.34 million for the quarter, compared to the consensus estimate of $130.89 million. Cerence had a positive trailing twelve-month return on equity of 2.53% and a negative net margin of 8.66%.

What guidance has Cerence issued on next quarter's earnings?

Cerence issued an update on its second quarter 2024 earnings guidance on Tuesday, February, 6th. The company provided EPS guidance of for the period. The company issued revenue guidance of $60.0 million-$64.0 million, compared to the consensus revenue estimate of $70.9 million.

What other stocks do shareholders of Cerence own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cerence investors own include NVIDIA (NVDA), Block (SQ), Fastly (FSLY), DocuSign (DOCU), PayPal (PYPL), Shopify (SHOP), Teladoc Health (TDOC), Alteryx (AYX), Lumentum (LITE) and Salesforce (CRM).

Who are Cerence's major shareholders?

Cerence's stock is owned by many different institutional and retail investors. Top institutional shareholders include Kovack Advisors Inc. (0.10%). Insiders that own company stock include Christophe Couvreur, Iqbal Arshad, Leanne Fitzgerald, Mark J Gallenberger, Prateek Kathpal, Sanjay Dhawan, Stefan Ortmanns and Thomas L Beaudoin.
View institutional ownership trends
.

How do I buy shares of Cerence?

Shares of CRNC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CRNC) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners